Effects of Combinatorial Ubiquitinated Protein-Based Nanovaccine and STING Agonist in Mice With Drug-Resistant and Metastatic Breast Cancer
Open Access
- 13 September 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
Abstract
We previously reported that enriched ubiquitinated proteins (UPs) from tumor cells have the potential to be used as immunotherapy vaccine against cancer. Here we enriched UPs from epirubicin (EPB)-induced multi-drug-resistant cancer stem-like breast cancer cell line (4T1/EPB) and tested the efficacy of α-Al2O3-UPs-4T1/EPB (short for UPs-4T1/EPB) as therapeutic vaccine alone and in combination with the stimulator of interferon genes (STING) agonist in mice with drug-resistant and metastatic breast cancer. Vaccination with UPs-4T1/EPB exerted profound anti-tumor effects through augmented specific CD8+ T cell responses and amplified T cell receptor diversity of tumor-infiltrating lymphocytes (TILs). Importantly, the combination with STING agonist further facilitated the migration of mature CD8α+ dendritic cells to the lymph nodes and the infiltration of TILs within tumors, resulting in primary tumor regression and pulmonary metastasis eradication in mice. Moreover, the cured mice were completely resistant against a subsequent rechallenge with the same tumor. Our study indicates that this novel combinatorial immunotherapy with UPs-4T1/EPB vaccine and STING agonist is effective in mice with drug-resistant and metastatic breast cancer.This publication has 61 references indexed in Scilit:
- Tumor-Derived Autophagosome Vaccine: Mechanism of Cross-Presentation and Therapeutic EfficacyClinical Cancer Research, 2011
- Multidrug-resistance proteins are weak tumor associated antigens for colorectal carcinomaBMC Immunology, 2011
- Drug Treatment of Cancer Cell Lines: A Way to Select for Cancer Stem Cells?Cancers, 2011
- Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell CharacteristicsJNCI Journal of the National Cancer Institute, 2010
- Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?Anti-Cancer Drugs, 2010
- MAGE-D1 inhibits proliferation, migration and invasion of human breast cancer cellsOncology Reports, 2009
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008
- BioVenn – a web application for the comparison and visualization of biological lists using area-proportional Venn diagramsBMC Genomics, 2008
- Expression of SART3 antigen and induction of CTLs by SART3-derived peptides in breast cancer patientsBritish Journal of Cancer, 2001
- The Glut athione S-Transferase Supergene Family: Regulation of GST and the Contribution of the lsoenzymes to Cancer Chemoprotection and Drug Resistance Part IICritical Reviews in Biochemistry and Molecular Biology, 1995